Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types



Newsletter Article


Policy Prescriptions for High Drug Costs: Experts Weigh In

FDA lower Rx drug prices

High prescription drug costs are a persistent problem in the United States. In a To the Point post, the Commonwealth Fund’s Shawn Bishop highlighted three Health Affairs papers in which policy experts explore ways to get pharmaceutical prices under control. By increasing competition in drug markets, applying value-based purchasing, and protecting patients from high out-of-pocket costs, they believe policymakers can begin to make affordable prescription drugs a reality. The papers were supported by the Commonwealth Fund and The Drug Pricing Lab of Memorial Sloan Kettering.

Publication Details